ATE165594T1 - Triarylethylenderivate zur therapeutischen verwendung - Google Patents
Triarylethylenderivate zur therapeutischen verwendungInfo
- Publication number
- ATE165594T1 ATE165594T1 AT94927182T AT94927182T ATE165594T1 AT E165594 T1 ATE165594 T1 AT E165594T1 AT 94927182 T AT94927182 T AT 94927182T AT 94927182 T AT94927182 T AT 94927182T AT E165594 T1 ATE165594 T1 AT E165594T1
- Authority
- AT
- Austria
- Prior art keywords
- therapeutic use
- derivatives
- triarylethylene
- agents
- triarylethylene derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12661493A | 1993-09-24 | 1993-09-24 | |
| US08/259,797 US5525633A (en) | 1993-09-24 | 1994-06-15 | Triaryl-ethylene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE165594T1 true ATE165594T1 (de) | 1998-05-15 |
Family
ID=26824862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94927182T ATE165594T1 (de) | 1993-09-24 | 1994-08-19 | Triarylethylenderivate zur therapeutischen verwendung |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5684004A (de) |
| EP (1) | EP0720597B1 (de) |
| JP (1) | JPH09503761A (de) |
| CN (1) | CN1131415A (de) |
| AT (1) | ATE165594T1 (de) |
| AU (1) | AU678535B2 (de) |
| CA (1) | CA2171728C (de) |
| DE (1) | DE69409961T2 (de) |
| DK (1) | DK0720597T3 (de) |
| ES (1) | ES2115975T3 (de) |
| FI (1) | FI961339L (de) |
| HU (1) | HUT75933A (de) |
| IL (1) | IL111018A0 (de) |
| NO (1) | NO306292B1 (de) |
| NZ (1) | NZ273433A (de) |
| PL (1) | PL177833B1 (de) |
| WO (1) | WO1995008528A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2147679B1 (de) | 2001-07-25 | 2014-06-25 | Raptor Pharmaceutical, Inc. | Zusammensetzungen für den Blut-Hirn-Schrankentransport |
| EP2392258B1 (de) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-Informatiksystem |
| CN101594878A (zh) | 2006-09-18 | 2009-12-02 | 雷普特药品公司 | 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗 |
| PL3395372T3 (pl) | 2009-02-20 | 2022-07-25 | EnhanX Biopharm Inc. | Układ do dostarczania leków na bazie glutationu |
| CN102458374A (zh) | 2009-05-06 | 2012-05-16 | 实验室护肤股份有限公司 | 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法 |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1099093A (en) * | 1965-09-03 | 1968-01-17 | Ici Ltd | Alkene derivatives |
| EP0002097B1 (de) * | 1977-08-22 | 1981-08-05 | Imperial Chemical Industries Plc | Triphenylalken-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten |
-
1994
- 1994-08-19 NZ NZ273433A patent/NZ273433A/en unknown
- 1994-08-19 CA CA002171728A patent/CA2171728C/en not_active Expired - Fee Related
- 1994-08-19 AT AT94927182T patent/ATE165594T1/de not_active IP Right Cessation
- 1994-08-19 DE DE69409961T patent/DE69409961T2/de not_active Expired - Fee Related
- 1994-08-19 AU AU76707/94A patent/AU678535B2/en not_active Ceased
- 1994-08-19 HU HU9600727A patent/HUT75933A/hu unknown
- 1994-08-19 WO PCT/US1994/009314 patent/WO1995008528A1/en not_active Ceased
- 1994-08-19 DK DK94927182T patent/DK0720597T3/da active
- 1994-08-19 JP JP7509757A patent/JPH09503761A/ja not_active Ceased
- 1994-08-19 FI FI961339A patent/FI961339L/fi not_active IP Right Cessation
- 1994-08-19 CN CN94193479A patent/CN1131415A/zh active Pending
- 1994-08-19 PL PL94313594A patent/PL177833B1/pl unknown
- 1994-08-19 ES ES94927182T patent/ES2115975T3/es not_active Expired - Lifetime
- 1994-08-19 EP EP94927182A patent/EP0720597B1/de not_active Expired - Lifetime
- 1994-09-21 IL IL11101894A patent/IL111018A0/xx unknown
-
1995
- 1995-06-05 US US08/463,792 patent/US5684004A/en not_active Expired - Fee Related
-
1996
- 1996-03-25 NO NO961204A patent/NO306292B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU7670794A (en) | 1995-04-10 |
| ES2115975T3 (es) | 1998-07-01 |
| NO306292B1 (no) | 1999-10-18 |
| IL111018A0 (en) | 1994-11-28 |
| DE69409961D1 (de) | 1998-06-04 |
| DK0720597T3 (da) | 1998-10-07 |
| EP0720597B1 (de) | 1998-04-29 |
| JPH09503761A (ja) | 1997-04-15 |
| PL313594A1 (en) | 1996-07-08 |
| CA2171728A1 (en) | 1995-03-30 |
| AU678535B2 (en) | 1997-05-29 |
| WO1995008528A1 (en) | 1995-03-30 |
| CA2171728C (en) | 2001-11-13 |
| FI961339A0 (fi) | 1996-03-22 |
| CN1131415A (zh) | 1996-09-18 |
| EP0720597A1 (de) | 1996-07-10 |
| NZ273433A (en) | 1997-11-24 |
| DE69409961T2 (de) | 1998-09-10 |
| US5684004A (en) | 1997-11-04 |
| NO961204D0 (no) | 1996-03-25 |
| PL177833B1 (pl) | 2000-01-31 |
| HUT75933A (en) | 1997-05-28 |
| FI961339A7 (fi) | 1996-03-22 |
| NO961204L (no) | 1996-03-25 |
| FI961339L (fi) | 1996-03-22 |
| HU9600727D0 (en) | 1996-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| ID23374A (id) | Halogenopirimidin | |
| MY104685A (en) | Substituted thiazoles and their use as fungicides. | |
| ATE238790T1 (de) | Verwendung von pramipexole als neuroschutzmittel | |
| EA199800667A1 (ru) | Новые фенантридины | |
| NO930615D0 (no) | Hypoglykemiske hydroksyurinstoffderivater | |
| DE69939864D1 (de) | Ppar-gamma modulatoren | |
| ATE148130T1 (de) | Typ-iv-dipeptidyl-aminopeptidase-inhibitoren | |
| NO990405L (no) | Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler | |
| DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
| TR200200068T2 (tr) | Nematisital triflüorobütenler | |
| GB9406857D0 (en) | Improvements in or relating to organic compounds | |
| PT1017659E (pt) | Tetra-hidronaftalenos substituidos e compostos analogos | |
| BG99177A (bg) | Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза | |
| BR9711586A (pt) | Compostos e uso dos mesmo | |
| KR960702830A (ko) | 방사선 보호제로서의 N-알킬티오 폴리아민 유도체(N-Alkylthio polyaine derivatives as radioprotective agents) | |
| DE69425820D1 (de) | Verwendung von ferrioxamin-b zur behandlung septischen schocks | |
| MX9101958A (es) | Inhibidores de acat de urea de aminosulfonilo | |
| MY105128A (en) | Bu-3608 derivatives. | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| ATE165594T1 (de) | Triarylethylenderivate zur therapeutischen verwendung | |
| BG101221A (bg) | N-заместени азабициклохептанови производни, приложими като невролептици | |
| DK0656889T3 (da) | 9-chlorprostaglandinestere og -amider og deres anvendelse ved fremstilling af lægemidler | |
| AU6832498A (en) | Substituted benzyl oximino compounds | |
| BR9808210A (pt) | Befeniloxazolinas dissubstituìdas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |